Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-000045
Filing Date
2021-01-04
Accepted
2021-01-04 11:31:50
Documents
72
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 608115
2 ex31-1.htm EX-31.1 19371
3 ex32-1.htm EX-32.1 6180
4 form10q_001.jpg GRAPHIC 26742
  Complete submission text file 0001493152-21-000045.txt   3224914

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE biopl-20200630.xml EX-101.INS 549839
6 XBRL SCHEMA FILE biopl-20200630.xsd EX-101.SCH 48866
7 XBRL CALCULATION FILE biopl-20200630_cal.xml EX-101.CAL 60144
8 XBRL DEFINITION FILE biopl-20200630_def.xml EX-101.DEF 122332
9 XBRL LABEL FILE biopl-20200630_lab.xml EX-101.LAB 256469
10 XBRL PRESENTATION FILE biopl-20200630_pre.xml EX-101.PRE 205956
Mailing Address NO.9 & 10, JALAN P4/8B BANDAR TEKNOLOGI KAJANG SEMENYIH, SELANGOR N8 43500
Business Address NO.9 & 10, JALAN P4/8B BANDAR TEKNOLOGI KAJANG SEMENYIH, SELANGOR N8 43500 60387032020
BIOPLUS LIFE CORP. (Filer) CIK: 0001746214 (see all company filings)

EIN.: 300987011 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-226885 | Film No.: 21500657
SIC: 5912 Retail-Drug Stores and Proprietary Stores